Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Aprogen Medicines Inc. (007460.KS), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
0.00
P/B ratioShare price divided by book value per share.
0.00
P/S ratioMarket value divided by annual revenue.
0.31
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-9.36
EV / RevenueEnterprise value against annual revenue.
3.85
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
24.91%
Operating marginRevenue left after operating costs.
-75.71%
Net marginRevenue left after every cost, including tax and interest.
-60.14%
Return on equityProfit as a percentage of shareholders’ equity.
-30.36%
Return on assetsProfit as a percentage of total assets.
-6.78%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
0.84
Quick ratioThe same, excluding inventory.
0.38
Debt to equityTotal borrowings against shareholders’ equity.
0.44
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$0.00
Book value per shareShareholders’ equity divided by shares outstanding.
$0.00
Shares outstandingShares currently issued.
22,185,944
Market capitalisationShare price times shares outstanding.
$43.15B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
311
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
0.00%
Aprogen Medicines Inc. (007460.KS) statistics — frequently asked questions
What is Aprogen Medicines Inc.'s return on equity?
Aprogen Medicines Inc. (007460.KS) reports a return on equity of -30.36%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does Aprogen Medicines Inc. carry?
Aprogen Medicines Inc. (007460.KS) has a debt-to-equity ratio of 0.44, which compares total borrowings with shareholders' equity.
What is Aprogen Medicines Inc.'s profit margin?
Aprogen Medicines Inc. (007460.KS) keeps -60.14% of revenue as net profit after every cost, including tax and interest.